Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bachir Benarba has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combined Assessment of Estimated Glomerular Filtration Rate and Albuminuria Among Apparently Healthy Young Adults: A Cross-Sectional Study

    by Adel Gouri, Wafa Taayat, Maissa Chiraz Rahim, Imed Miadi, Rima Laskri, Sarra Chine, Younes Benchaar, Saddek Benharkat, Bachir Benarba

  • Open Access

    Brain-on-a-chip technology for modeling psychiatric disorders: A new frontier in precision psychiatry

    by Taslim Uddin, Adel Gouri, Faria Sharmin, Khadidja Belhouala, Nusrat Jahan Nisha, Nazifa Anjum, Susmita Biswas, Sajid Asgar, Sarah Tahera Mahmud, Afia Asma, et al.

    Brain-on-a-chip (BoC) technology is an emerging human-relevant platform for investigating complex neuropsychiatric disorders, including major depressive disorder (MDD) and schizophrenia. By integrating microfluidic systems with human induced pluripotent stem cell (iPSC)-derived neural cells, three-dimensional cultures, multiregion architectures, microelectrode arrays, and biosensors, BoC platforms enable controlled investigation of neural connectivity, network activity, and cellular interactions. iPSC-based models provide disease-relevant phenotypes that may support the development of more complex psychiatric BoC systems; however, dedicated and comprehensively validated BoC models for MDD and schizophrenia remain limited. Important challenges include incomplete cellular maturation and complexity, limited vascular and immune integration, technical variability, long-term stability, and insufficient clinical validation. Future advances integrating patient-specific cells, artificial intelligence, multi-omics, and standardized multimodal measurements may improve disease modeling and therapeutic research. With rigorous disease-specific validation and stronger links to clinically characterized data, BoC technology may contribute to the future development of precision psychiatry.

  • Open Access

    Science in peril: let's fund scientific research in a sustainable and equitable way - a call for international solidarity

    by Bachir Benarba, Atanasio Pandiella, Said Hachimi-Idrissi, Francesca Rubulotta, Eddy Lang, Abdelouahab Bellou

  • Open Access

    The Inhibitory Effect of Selenium Supplementation on Tumor Progression in a DMBA-Induced Breast Cancer Model in Wistar Rats

    by Nour El-Houda Feriel Djebara, Adel Gouri, Houari Hemida, Chahinaize Zaoui, Bachir Benarba

    Background: Breast cancer remains a significant global public health concern, necessitating the ongoing exploration of novel preventive and therapeutic strategies. Selenium supplementation has been proposed as a potential chemopreventive agent, yet its efficacy lacks robust in vivo validation. Aims: This study aimed to evaluate the chemopreventive potential of selenium supplementation and its effect on tumor progression in a 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer model in Wistar rats. Methods: Twenty-four adult female Wister rat were allocated into four experimental groups (n=6): Control (vehicle only); DMBA (carcinogen control); DMBA + Se 200 µg/kg; and DMBA + Se 400 µg/kg. Mammary tumors were induced via a single intragastric administration of DMBA (80 mg/kg). Over a 23-week period, hematological, biochemical, and histopathological analyses were conducted. The volume of excised mammary tumors was measured post-sacrifice. Results: Supplementation with selenium at a dose of 400 µg/kg resulted in a statistically significant reduction in mean tumor volume (0.13 cm³) compared to the DMBA-only group (1.32 cm³). Concurrently, this high-dose group exhibited significant amelioration in serum levels of specific biochemical markers including aspartate aminotransferase (AST), urea, and creatinine. Histopathological assessment further supported these findings, revealing a more preserved mammary tissue architecture in rats receiving the high-dose selenium. Conclusions: While selenium supplementation at 400 µg/Kg demonstrated a significant inhibition effect on tumor progression and conferred hepatorenal protection, a definitive chemopreventive effect against DMBA-induced carcinogenesis was not established. These results indicate that selenium may function as a therapeutic modulator rather than a primary preventive agent in this model. Further investigation employing higher doses and alternative administration regimens is warranted to elucidate its full chemopreventive potential. Keywords: Breast cancer; Selenium; DMBA; Chemoprevention; Tumor Progression; Wistar rats.


  • HPLC–DAD phenolic profile, antioxidant, anti-inflammatory, and anticancer activities of Bryonia cretica subsp. dioica (Jacq.) Tutin. (Cucurbitaceae)

    by Khadidja Belhouala, Cansu Korkmaz, Meltem Taş-Küçükaydin, Selçuk Küçükaydin, Mehmet Emin Duru, Bachir Benarba


  • Open Access

    Gas Chromatography-Mass Spectrometry (GC-MS), in silico and in vitro investigations of antioxidant and anti-inflammatory activities of Sinapis alba L. seed essential oil

    by Khadidja Belhouala, Youcef Bouhedda, Teffaha Fergoug, Zineddine Daikh, Kaddour Miloudi, Bachir Benarba

    This study aims to identify the chemical constituents of Sinapis alba L. seeds essential oil and evaluate its antioxidant and anti-inflammatory activities. The chemicals were determined using Gas Chromatography-Mass Spectrometry (GC-MS), followed by predicting their biological potential in silico. Then, evaluation of their antioxidant activities in vitro using DPPH, FRAP, and Hydrogen Peroxide (H2O2) assays. Similarly, the anti-inflammatory activities were investigated through HRBC membrane stabilization, serum albumin denaturation, and proteinase inhibition assays. Our results showed that 3-butenyl isothiocyanate (58.36%), phenethyl isothiocyanate (0.95%), methallyl cyanide (0.64%), silane, ethenylethoxydimethyl- (0.51%), N-(3-methyl-2-butenyl)acetamide (0.50%), 4,5-epithiovaleronitrile (0.42%), and 3-carene (0.38%) were the major compounds revealed by GC-MS analysis. After passing the Lipinski rule, the compounds were predicted to be non-hepatotoxic agents, while the molecular docking manifested a great binding affinity between some target-ligand complex. Regarding the experimental study, S. alba essential oil showed significant antioxidant activity: DPPH (IC50 = 394.42 ± 0.01 mg/mL), H2O2 (IC50 = 498.81 ± 0.52 mg/mL), and FRAP (IC50 = 95.45 ± 0.03 mg/mL). Besides, the anti-inflammatory tests including HRBC membrane stabilization, serum albumin denaturation, and proteinase inhibition established values of 34.77 ± 0.08%, 95 ± 0.01%, and 50.61 ± 0.03%, respectively. Taken together, our results demonstrate that S. alba L. seeds essential oil have potential antioxidant as well as anti-inflammatory properties, that could be a scope for further research and potential use in pharmaceutical products.

  • Open Access

    Phenolic profile, antioxidant, anti-inflammatory and anticancer activities of Telephium imperati L.

    by Bachir Benarba, Khadidja Belhouala, Cansu Korkmaz, Meltem Taş Küçükaydın, Selçuk Küçükaydın, Mehmet Emin Duru

    Telephium imperati L. is one of the most valuable spices used by Algerians for food and different medicinal purposes. Here, we report the main phenolic compounds of T. imperati that grows in arid regions and its antioxidant, anti-inflammatory, and anticancer activities. The phenolic profiles of methanolic and aqueous extracts of T. imperati roots was obtained using HPLC-DAD, whereas antioxidant activity was evaluated using 2.2-diphenyl-1-picrylhydrazyl (DPPH), potassium ferricyanide, and Hydrogen peroxide (H2O2) assays. Moreover, the anti-inflammatory activity was investigated by measuring the level of protection of the human red blood cell (HRBC) membrane against hypotonicity-induced lysis. The anticancer activity was evaluated using the MTT assay against three human cancer cell lines (HT-29, PC-3, A-549) and one non-tumorigenic (CCD18-Co) cells. Our results showed that the methanolic extract was rich in phenols (493.17±0.0 mg GAE/g), flavonoids (271.56±0.1 mg QE/g), and tannins (106.50±2.3 mg CE/g). The HPLC-DAD analysis revealed that caffeic acid (78.61 mg/g), ferulic acid (49.12 mg/g), rosmarinic acid (42.80 mg/g), coumarin (39.87 mg/g), rutin (37.68 mg/g), myricetin (25.62 mg/g), syringic acid (18.90 mg/g), and quercetin (18.65 mg/g) were mainly present in T. imperati extracts. Although the DPPH assay showed slight antioxidant activity for both extracts, the methanolic extract exhibited significant potent anti-inflammatory action in all in vitro tests, protecting HRBC damage and BSA denaturation at rates of 80.18 and 97.62%, respectively. Likewise, the methanolic extract exhibited an important anticancer activity against the HT-29 and A-549 cell lines, with IC50 values ranging from 1.85 to 2.00 log10 μg/mL. Interestingly, no toxic effects on CCD18-Co were observed. Therefore, the present study revealed that T. imperati root extracts are rich in phenolic compounds and could be a promising source of anti-inflammatory and anticancer molecules.


  • Action Mechanism of Bioactive Compounds from Plants and Spices Mixture as Promising Anticancer Agents: In Silico Drug Design Predictions Targeting Cancer Cell Proliferation Through Cell Cycle Arrest Pathway

    by Bachir Benarba, Khadidja Belhouala, Atanasio Pandiella

    Although cancer has been the main reason for death for decades, until now, no safe certified drugs have been discovered to efficiently inhibit its progression. Currently, we aim to employ an in-silico model to predict the action mechanism of phenolic components that we previously demonstrated as inhibitors of colon, prostate and lung cancer. The work was performed by testing pharmacokinetics and pharmacodynamics proprieties of selected molecules. Four compounds: Kaempferol, chrysin, vanillin and p-hydroxybenzoic acid widely obeyed the five rules and the ADME/T criteria with minimum toxicity. Docking prediction recorded an intense affinity between kaempferol- CDK1(−17.72 ± 0.02 kcal/mol), chrysin-CDK1 (−17.61 ± 0.01 kcal/mol) and kaempferol-caspase 8 (−9.30 ± 0.00 kcal/mol), chrysin-caspase 8 (−8.18 ± 0.12 kcal/mol), vanillin-MMP9 (−9.83 ± 0.04 kcal/mol) and p-hydroxybenzoic acid-Ca2 (−8.91 ± 0.01 kcal/mol). Likewise, MMGBSA results demonstrated that these compounds are evidently bound to the targets’ active sites with solid interactions. The passed compounds might target the responsible factors for transcription as inactivators. The molecular mechanism based on kaempferol and vanillin actions was predicted to target CDK1 and MMP9 via cell cycle arrest and apoptosis. All results were confirmed through RMSD analysis suggesting that kaempferol and vanillin are the best ligands to suppress cancer cell proliferation. Thus, these findings allowed us to imagine a potential molecular mechanism of these binaries, phenolic compounds/target proteins to lead further trails on cancer, of which the synergistic activity between phenolic compounds could promote the therapeutic capacity.


  • Comparison of Essential Oils of Schinus molle L. Leaves Growing in Different Regions of Algeria in Terms of Their Chemical Compositions and Various Biological Activities

    by Amina Kouachi, Zohra Madani, Meltem Taş‐ Küçükaydın, Büşra Eroğlu, Cansu Korkmaz, Khadidja Belhouala, Selçuk Küçükaydın, Adel Aouiche, Özgür Ceylan, Mehmet Emin Duru, et al.

    This preliminary study investigated the chemical composition and biological properties of essential oils derived from Schinus molle L. leaves obtained from three specific regions in Algeria: Algiers (SMA), Djelfa (SMD), and Mascara (SMM). Gas chromatography (GC) and Gas chromatography–Mass Spectrometry (GC–MS) analyses confirmed the presence of 52 compounds (100.0%) in SMA essential oil, 50 compounds (100.0%) in SMD, and 72 compounds (100.0%) in SMM essential oils. The main components of SMA oil were camphene (31.82%), limonene (14.71%), and p‐cymene (9.25%). In SMD and SMM oils, α‐phellandrene (14.25% and 12.70%), limonene (13.02% and 11.90%), and germacrene D (10.62% and 10.15%) were the major components, respectively. The antioxidant characteristics were evaluated using five methods: β‐carotene‐linoleic acid, DPPH, ABTS+, CUPRAC, and Metal chelating assays. The results revealed a moderate to low anti‐oxidant effect, with SMA essential oils exhibiting the highest activity. A moderate inhibitory effect against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), α‐glucosidase, α‐amylase, urease, and tyrosinase was observed, indicating anti‐enzymatic activity. Nevertheless, all samples had higher IC50 values for both antioxidant and anti‐enzymatic activities than 200 μg/mL. It was determined that regional differences in the locations where S. molle grows showed both qualitative and quantitative differences in essential oil components. This difference was also detected in the biological activities of the essential oils. The anti‐inflammatory capacities of the three samples were assessed using Human Red Blood Cell (HRBC) membrane stabilisation and egg albumin denaturation techniques. The results showed effective anti‐inflammatory activity in all three samples. The antimicrobial efficacy was evaluated using a range of tests, such as anti‐quorum sensing, violacein inhibition, anti‐swimming, and anti‐swarming assays, demonstrating moderate activity. No toxic effects were observed at the tested dosages when assessing cytotoxicity against a healthy cell line (CCD18‐Co). This thorough examination provides valuable insights into the chemical composition and bioactive properties of essential oils derived from S. molle. These findings indicate the possible use of these essential oils in the food, medicinal, and cosmetic industries.